BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 34386036)

  • 1. Detection of Cell Types Contributing to Cancer From Circulating, Cell-Free Methylated DNA.
    Barefoot ME; Loyfer N; Kiliti AJ; McDeed AP; Kaplan T; Wellstein A
    Front Genet; 2021; 12():671057. PubMed ID: 34386036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments.
    Deger T; Boers RG; de Weerd V; Angus L; van der Put MMJ; Boers JB; Azmani Z; van IJcken WFJ; Grünhagen DJ; van Dessel LF; Lolkema MPJK; Verhoef C; Sleijfer S; Martens JWM; Gribnau J; Wilting SM
    Clin Epigenetics; 2021 Oct; 13(1):196. PubMed ID: 34670587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational challenges in detection of cancer using cell-free DNA methylation.
    Sharma M; Verma RK; Kumar S; Kumar V
    Comput Struct Biotechnol J; 2022; 20():26-39. PubMed ID: 34976309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Liquid biopsy in colorectal cancer : An overview of ctDNA analysis in tumour diagnostics].
    Haupts A; Roth W; Hartmann N
    Pathologe; 2019 Dec; 40(Suppl 3):244-251. PubMed ID: 31797045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid biopsies based on cell-free DNA as a potential biomarker in head and neck cancer.
    Rapado-González Ó; Rodríguez-Ces AM; López-López R; Suárez-Cunqueiro MM
    Jpn Dent Sci Rev; 2023 Dec; 59():289-302. PubMed ID: 37680614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications.
    Volckmar AL; Sültmann H; Riediger A; Fioretos T; Schirmacher P; Endris V; Stenzinger A; Dietz S
    Genes Chromosomes Cancer; 2018 Mar; 57(3):123-139. PubMed ID: 29205637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of tissue-specific cell death using methylation patterns of circulating DNA.
    Lehmann-Werman R; Neiman D; Zemmour H; Moss J; Magenheim J; Vaknin-Dembinsky A; Rubertsson S; Nellgård B; Blennow K; Zetterberg H; Spalding K; Haller MJ; Wasserfall CH; Schatz DA; Greenbaum CJ; Dorrell C; Grompe M; Zick A; Hubert A; Maoz M; Fendrich V; Bartsch DK; Golan T; Ben Sasson SA; Zamir G; Razin A; Cedar H; Shapiro AM; Glaser B; Shemer R; Dor Y
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1826-34. PubMed ID: 26976580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer.
    Wyatt AW; Annala M; Aggarwal R; Beja K; Feng F; Youngren J; Foye A; Lloyd P; Nykter M; Beer TM; Alumkal JJ; Thomas GV; Reiter RE; Rettig MB; Evans CP; Gao AC; Chi KN; Small EJ; Gleave ME
    J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 29206995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using circulating cell-free DNA to monitor personalized cancer therapy.
    Oellerich M; Schütz E; Beck J; Kanzow P; Plowman PN; Weiss GJ; Walson PD
    Crit Rev Clin Lab Sci; 2017 May; 54(3):205-218. PubMed ID: 28393575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of the mutational landscape and fragmentation of circulating tumor DNA in renal cell carcinoma.
    Yamamoto Y; Uemura M; Fujita M; Maejima K; Koh Y; Matsushita M; Nakano K; Hayashi Y; Wang C; Ishizuya Y; Kinouchi T; Hayashi T; Matsuzaki K; Jingushi K; Kato T; Kawashima A; Ujike T; Nagahara A; Fujita K; Imamura R; Nakagawa H; Nonomura N
    Cancer Sci; 2019 Feb; 110(2):617-628. PubMed ID: 30536551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation analysis of tumor suppressor genes in liquid biopsy components of early stage NSCLC: a promising tool for early detection.
    Markou Α; Londra D; Tserpeli V; Kollias Ι; Tsaroucha E; Vamvakaris I; Potaris K; Pateras I; Kotsakis Α; Georgoulias V; Lianidou Ε
    Clin Epigenetics; 2022 May; 14(1):61. PubMed ID: 35538556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
    Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
    Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Cell-Free DNA in Hepatocellular Carcinoma: Current Insights and Outlook.
    Ng CKY; Di Costanzo GG; Terracciano LM; Piscuoglio S
    Front Med (Lausanne); 2018; 5():78. PubMed ID: 29632864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-Free DNA Methylation Profiling Analysis-Technologies and Bioinformatics.
    Huang J; Wang L
    Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31698791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review.
    Petit J; Carroll G; Gould T; Pockney P; Dun M; Scott RJ
    J Surg Res; 2019 Apr; 236():184-197. PubMed ID: 30694754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive DNA methylation analysis of tissue of origin of plasma cell-free DNA by methylated CpG tandem amplification and sequencing (MCTA-Seq).
    Liu X; Ren J; Luo N; Guo H; Zheng Y; Li J; Tang F; Wen L; Peng J
    Clin Epigenetics; 2019 Jun; 11(1):93. PubMed ID: 31234922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined multimodal ctDNA analysis and radiological imaging for tumor surveillance in Non-small cell lung cancer.
    Metzenmacher M; Hegedüs B; Forster J; Schramm A; Horn PA; Klein CA; Bielefeld N; Ploenes T; Aigner C; Theegarten D; Schildhaus HU; Siveke JT; Schuler M; Lueong SS
    Transl Oncol; 2022 Jan; 15(1):101279. PubMed ID: 34800919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Tissue-Free Method to Estimate Tumor-Derived Cell-Free DNA Quantity Using Tumor Methylation Patterns.
    Melton CA; Freese P; Zhou Y; Shenoy A; Bagaria S; Chang C; Kuo CC; Scott E; Srinivasan S; Cann G; Roychowdhury-Saha M; Chang PY; Singh AH
    Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA.
    Luo H; Wei W; Ye Z; Zheng J; Xu RH
    Trends Mol Med; 2021 May; 27(5):482-500. PubMed ID: 33500194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Targeted Q-PCR-Based Method for Point Mutation Testing by Analyzing Circulating DNA for Cancer Management Care.
    Thierry AR
    Methods Mol Biol; 2016; 1392():1-16. PubMed ID: 26843041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.